688253 Stock Overview
Engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 6/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 688253 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Innovita Biological Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥38.95 |
| 52 Week High | CN¥52.69 |
| 52 Week Low | CN¥23.61 |
| Beta | 1.17 |
| 1 Month Change | -11.54% |
| 3 Month Change | 5.76% |
| 1 Year Change | 57.25% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 18.03% |
Recent News & Updates
We Think Innovita Biological Technology's (SHSE:688253) Robust Earnings Are Conservative
Nov 01
Investors Could Be Concerned With Innovita Biological Technology's (SHSE:688253) Returns On Capital
Sep 28Recent updates
We Think Innovita Biological Technology's (SHSE:688253) Robust Earnings Are Conservative
Nov 01Investors Could Be Concerned With Innovita Biological Technology's (SHSE:688253) Returns On Capital
Sep 28Statutory Profit Doesn't Reflect How Good Innovita Biological Technology's (SHSE:688253) Earnings Are
Apr 22There's Reason For Concern Over Innovita Biological Technology Co., Ltd.'s (SHSE:688253) Massive 25% Price Jump
Mar 20Shareholder Returns
| 688253 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -3.5% | -2.8% | -1.2% |
| 1Y | 57.2% | -9.2% | 11.8% |
Return vs Industry: 688253 exceeded the CN Medical Equipment industry which returned -9.2% over the past year.
Return vs Market: 688253 exceeded the CN Market which returned 11.8% over the past year.
Price Volatility
| 688253 volatility | |
|---|---|
| 688253 Average Weekly Movement | 8.1% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 688253 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688253's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 453 | Xiujie Zhang | www.innovita.com.cn |
Innovita Biological Technology Co., Ltd. engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products. The company offers pathogen detection and joint detection of multiple pathogen; emergency outpatient testing; coronavirus testing; respiratory infections solutions; pregnancy test; hepatitis virus testing ; and enterovirus testing . The company was founded in 2006 and is based in Beijing, China.
Innovita Biological Technology Co., Ltd. Fundamentals Summary
| 688253 fundamental statistics | |
|---|---|
| Market cap | CN¥5.32b |
| Earnings (TTM) | CN¥332.01m |
| Revenue (TTM) | CN¥720.40m |
16.0x
P/E Ratio7.4x
P/S RatioIs 688253 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688253 income statement (TTM) | |
|---|---|
| Revenue | CN¥720.40m |
| Cost of Revenue | CN¥160.64m |
| Gross Profit | CN¥559.76m |
| Other Expenses | CN¥227.75m |
| Earnings | CN¥332.01m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.43 |
| Gross Margin | 77.70% |
| Net Profit Margin | 46.09% |
| Debt/Equity Ratio | 0% |
How did 688253 perform over the long term?
See historical performance and comparisonDividends
1.0%
Current Dividend Yield16%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 01:55 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Innovita Biological Technology Co., Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Wen Dai | Huatai Research |